MetaMedical™ Solutions Inc

Healthcare sector remains a prime target for cyberattacks

It is suspected that $22 million was paid to the perpetrators of the cyberattack on Change Healthcare. Credit: MaximP via Shutterstock. The large-scale cyberattack on Change Healthcare in February 2024 is a stark reminder that digital healthcare infrastructure is both vital to people’s daily lives and vulnerable to attack. The incident broke down the company’s […]

Researchers develop 3D imaging probe for cancer cell detection

The new probe will make it possible to perform histology, based on abnormal stiffness at the single cell level. Credit: Nemeziya/Shutterstock. A research team at the University of Nottingham has developed an endoscopic probe enabling practitioners to three-dimensionally (3D) image the stiffness of individual biological cells and complex organisms to discover and treat cancer earlier. […]

IceCure seeks FDA approval for cryoablation for breast cancer

ProSense cryoablation system can destroy tumours by freezing, using liquid nitrogen. Credit: CI Photos/Shutterstock.com. IceCure Medical has submitted final data to the US Food and Drug Administration (FDA) seeking marketing authorisation for its ProSense cryoablation system to treat early-stage T1 invasive breast cancer. ProSense is a minimally invasive treatment intended to destroy tumours by freezing, […]

Paragonix heart transplant trial cuts graft dysfunction by half

The Paragonix trial also also saw a 5% increase in two-year survival as well as a 43% reduction in two-year mortality. Credit: Shutterstock / VesnaArt US-based organ transplant company, Paragonix, has announced a trial of its SherpaPak organ preservation system saw a 50% reduction in severe primary graft dysfunction. The results of the GUARDIAN-Heart trial […]

Labcorp launches test for neurodegenerative diseases detection

The GFAP blood biomarker test complements Labcorp’s existing neurology tests. Credit: PaeGAG/Shutterstock.com. Global life sciences company Labcorp has announced the first commercially available glial fibrillary acidic protein (GFAP) blood biomarker test in the US, offering a new tool for the early detection of neurodegenerative diseases and brain injuries. The new tool measures GFAP, an early-stage […]

3D Systems obtains FDA 510(k) clearance for cranial implant

The VSP PEEK Cranial Implant for cranioplasty procedures to restore skull defects. Credit: 3D Systems. 3D Systems has received 510(k) clearance from the US Food and Drug Administration (FDA) for its VSP PEEK Cranial Implant. The patient-specific implant includes the EXT 220 MED 3D printer and represents a significant advancement in cranial reconstruction technology. It […]

TELA Bio launches OviTex IHR for inguinal hernia repair in US

OviTex IHR is designed for use as a surgical mesh to strengthen and/or repair tissue. Credit: MAD.vertise/Shutterstock.com. Medical technology company TELA Bio has announced the commercial launch of OviTex IHR (Inguinal Hernia Repair) Reinforced Tissue Matrix, a product tailored for laparoscopic and robotic-assisted procedures, in the US. The move is intended to meet the demand […]

EU to reportedly start China probe over medical device procurement

China has a 2025 target of having an 85% market share for Chinese companies producing core medical device components. Image credit: Shutterstock/InkheartX. The European Union (EU) is set to launch an investigation into how China carries out medical device procurement, as reported by Bloomberg on 15 April. The inquiry will reportedly seek to address concerns […]

EC approves Illumina’s Grail divestment plan

Grail is engaged in developing blood-based cancer tests. Credit: Sai Thaw Kyar/Shutterstock.com. The European Commission (EC) has granted approval to Illumina’s divestment plan for cancer test-maker Grail, aligning with the EU Merger Regulation. This follows the Commission’s directive from October 2023, mandating Illumina to reverse its acquisition of Grail to reinstate pre-transaction competition levels. In […]

Co-Diagnostics opens new manufacturing facility in Utah, US

Officials from Co-Diagnostics, among others, during the facility’s opening ceremony. Credit: PRNewswire/Co-Diagnostics. Co-Diagnostics (Co-Dx), a molecular diagnostics company, has officially opened a new manufacturing facility in South Salt Lake, Utah, in the US. Located at 3222 S. Washington Street, the facility is expected to bring quality polymerase chain reaction (PCR) (molecular) testing to homes as […]